These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23510020)

  • 1. Have we learnt all we need to know from genetic studies - is genetics over in Alzheimer's disease?
    Hampel H; Lista S
    Alzheimers Res Ther; 2013; 5(2):11. PubMed ID: 23510020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in Sporadic and Familial Alzheimer's Disease.
    Lista S; O'Bryant SE; Blennow K; Dubois B; Hugon J; Zetterberg H; Hampel H
    J Alzheimers Dis; 2015; 47(2):291-317. PubMed ID: 26401553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Search for risk genes in Alzheimer's disease].
    Karaca I; Wagner H; Ramirez A
    Nervenarzt; 2017 Jul; 88(7):744-750. PubMed ID: 28577227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.
    Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD
    JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer's disease.
    Toomey CE; Heywood W; Benson BC; Packham G; Mills K; Lashley T
    Brain Pathol; 2020 Jul; 30(4):794-810. PubMed ID: 32267026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREM2 R47H variant and risk for Alzheimer's disease: assessment in a Greek population and updated meta-analysis.
    Rikos D; Siokas V; Mentis AA; Aloizou AM; Liampas I; Tsouris Z; Peristeri E; Stamati P; Hadjigeorgiou GM; Dardiotis E
    Int J Neurosci; 2022 Dec; ():1-9. PubMed ID: 36408688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant
    Cheng Q; Danao J; Talreja S; Wen P; Yin J; Sun N; Li CM; Chui D; Tran D; Koirala S; Chen H; Foltz IN; Wang S; Sambashivan S
    J Biol Chem; 2018 Aug; 293(32):12620-12633. PubMed ID: 29599291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TREM2 variants and risk of Alzheimer's disease: a meta-analysis.
    Lu Y; Liu W; Wang X
    Neurol Sci; 2015 Oct; 36(10):1881-8. PubMed ID: 26037549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.
    Ferrer I
    Free Neuropathol; 2022 Jan; 3():. PubMed ID: 37284149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease.
    Golde TE; Streit WJ; Chakrabarty P
    Alzheimers Res Ther; 2013; 5(3):24. PubMed ID: 23692967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
    Volloch V; Olsen BR; Rits S
    Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variant of TREM2 associated with the risk of Alzheimer's disease.
    Jonsson T; Stefansson H; Steinberg S; Jonsdottir I; Jonsson PV; Snaedal J; Bjornsson S; Huttenlocher J; Levey AI; Lah JJ; Rujescu D; Hampel H; Giegling I; Andreassen OA; Engedal K; Ulstein I; Djurovic S; Ibrahim-Verbaas C; Hofman A; Ikram MA; van Duijn CM; Thorsteinsdottir U; Kong A; Stefansson K
    N Engl J Med; 2013 Jan; 368(2):107-16. PubMed ID: 23150908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.
    Ruiz A; Dols-Icardo O; Bullido MJ; Pastor P; Rodríguez-Rodríguez E; López de Munain A; de Pancorbo MM; Pérez-Tur J; Alvarez V; Antonell A; López-Arrieta J; Hernández I; Tárraga L; Boada M; Lleó A; Blesa R; Frank-García A; Sastre I; Razquin C; Ortega-Cubero S; Lorenzo E; Sánchez-Juan P; Combarros O; Moreno F; Gorostidi A; Elcoroaristizabal X; Baquero M; Coto E; Sánchez-Valle R; Clarimón J;
    Neurobiol Aging; 2014 Feb; 35(2):444.e1-4. PubMed ID: 24041969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.
    Pottier C; Wallon D; Rousseau S; Rovelet-Lecrux A; Richard AC; Rollin-Sillaire A; Frebourg T; Campion D; Hannequin D
    J Alzheimers Dis; 2013; 35(1):45-9. PubMed ID: 23380991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease.
    Cheng-Hathaway PJ; Reed-Geaghan EG; Jay TR; Casali BT; Bemiller SM; Puntambekar SS; von Saucken VE; Williams RY; Karlo JC; Moutinho M; Xu G; Ransohoff RM; Lamb BT; Landreth GE
    Mol Neurodegener; 2018 Jun; 13(1):29. PubMed ID: 29859094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains.
    Ma L; Allen M; Sakae N; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Younkin SG; Sevlever D
    Mol Neurodegener; 2016 Nov; 11(1):72. PubMed ID: 27887626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Common to Rare Variants: The Genetic Component of Alzheimer Disease.
    Nicolas G; Charbonnier C; Campion D
    Hum Hered; 2016; 81(3):129-141. PubMed ID: 28002825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The most prevalent rare coding variants of TREM2 conferring risk of Alzheimer's disease: A systematic review and meta-analysis.
    Li R; Wang X; He P
    Exp Ther Med; 2021 Apr; 21(4):347. PubMed ID: 33732320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative Splicing Regulation of Low-Frequency Genetic Variants in Exon 2 of
    Han S; Na Y; Koh I; Nho K; Lee Y
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.